Group A Streptococcus has been identified as a possible etiologic agent in psoriasis in epidemiologic, immunologic, immunopathologic, medical, and surgical 
Introduction
Psoriasis is a chronic immunomediated inflammatory disease that affects 2 to 3% of adults.' Patients with psoriasis develop erythematous, scaly plaques on their skin along with disfiguring nail and joint involvement. Affected patients are more likely to experience major depression and have a higher risk of developing certain cardiovascular comorbidities, further contributing to the debilitating nature of the disease.1,2
The pathogenesis of psoriasis is multifactorial. It involves an intricate interplay between the immune system , individual genetics, and the environment. One environmental factor of particular interest is the connection between tonsillar infection with group A Streptococcus and the development and maintenance of the psoriatic phenotype. It has been well reported that group A streptococcal pharyngitis often precedes the development of guttate psoriasis. ' Epidemiologic studies have shown that the prevalence of environmental group A Streptococcus correlates with the incidence of psoriasis.' Moreover, psoriasis patients who have been treated with long-term penicillin injections have reported a very Significant improvement in their Psoriasis Area and Severity Index (PAS!) score.' This connection notwithstanding, there is insufficient evidence demonstrating that persistent group A streptococcal infection is present in plaque psoriasis because
(1) the group A pathogen Streptococcus pyogenes is not easily cultured and (2) elevated antistreptolysin titers are not present in all affected individuals." One possible explanation for the lack ofculturability and the lack of serum markers is evasion of the host's immune response via the formation ofintricate biofilms within the tonsils. Evasion of the immune system promotes bacterial growth and survival despite the use of antistreptococcal agents, which are unable to penetrate the biofilms.
Biofilmsare clusters of microorganisms that adhere to biologicor nonbiologic surfaces. Theyexist in a matrixof extracellular polysaccharides, amyloid, adhesive fibers, and DNA. The term extracellularpolysaccharides refers to the biomass outside the bacteria, which makes up the bulk of the biofilm: the term intracellular biofilms refers to the biofilms within the host cells. The bacteria manufacture both the extracellular polysaccharides and the amyloid, which form the infrastructure ofthe biofilm. 
Images show stains of tonsillar specimens obtained from a patient with psoriasis. A: PAS staining shows an extracellular biomass (red arrow) that consists mostly of polysaccharides. An intracellular biofilm with retained nuclei (black arrows) is also seen (orĩi nal magnification x40). B: Congo redstainingispositive for amyloidin the cells cytoplasm, which forms the infrastructure of biofilms (black arrows). The nucleiof these cells are clearly present. Large areas of staining (without nuclei) represent extracellular biofilms (white arrows) (original magnification x40).
In a meta-analysis of studies of tonsiIIectomy and psoriasis, Thorleifsdottir et al concluded that tonsillectomy was a worthwhile treatment in 70% of psoriasis patients.' In a recent surgical study, Rachakonda et al found that tonsiIIectomy reversed the development of plaque psoriasis in 13 of 15 patients."
In this article, we describe our investigation aimed at evaluating the presence ofbiofilms in tonsillectomy specimens obtained from patients with psoriasis.
Materials and methods
We performed a histopathologic analysis of tonsillectomy specimens obtained from 10 patients-6 men and 4 women, aged 25 to 64 years (mean: 48)-who had been given a clinical diagnosis of plaque psoriasis. We compared the findings in these specimens with those of an age-and sex-matched control group of patients with chronic tonsillitis who did not have . psoriasis. All tonsillar specimens were stained with routine hematoxylin and eosin, periodic acid-Schiff (PAS), and Congo red. Routine light microscopy was employed for evaluation.
All protocols were approved by the Drexel University College of Medicine Institutional Review Board.
Results
On gross examination, we found no appreciable differences in the tonsillectomy specimens between the psoriasis patients and the controls. On histopathologic evaluation. all tonsillectomy specimens from the psoriasis patients demonstrated positive extra-and intracellular staining with both PAS and Congo red. The positive PAS staining indicated the presence of polysaccharides ( figure 1, A) , while the positive Congo red staining indicated the presence of amyloid ( figure 1,  B) . The tonsillectomy specimens from the controls exhibited similar features.
Uninvolved crypts that showed no PAS or Congo red staining were present in both cohorts (figure 2). Using these crypts as internal controls could possibly make for a better evaluation.
Discussion
To the best of our knowledge, this is the first study to look for the presence of tonsillar extra-and intracelIular biofilms in patients with psoriasis. As evidenced by the positive PAS and Congo red staining within the tonsillar epithelial cells, our results showed that group A streptococcal organisms persist within intracellular biofilms in psoriasis patients. Extracellular biofilms are evident, as well. These findings raise important considerations regarding the role of group A streptococcal infection in the pathogenesis of psoriasis.
One of these considerations is that the psoriatic phenotype may be propagated by chronic group A streptococcal tonsillitis. This is supported by the work of El-Rachkidyet al, who found that a significantlygreater number of patients with chronic plaque psoriasis had elevated titers of IgG-reactive proteins to S pyogenes compared with healthy age-and sex-matched controls." Support for this consideration was reported by Zhang et al, who found Toll-like receptor 2 in the upper dermal capillaries in psoriatic plaques." It appears that both the innate and adaptive immune systems may be involved.
The concept of group A Streptococcus as a pathogen in psoriasis was further corroborated in a study by Saxena and Dogra, who found that patients exhibited a significant improvement in PASI scores after receiving long-term penicillin or azithromycin therapy for chronic plaque psoriasis." However, they noted that 20% oftheir patients had developed a recurrence oftheir symptoms at 1 year of follow-up. S.lI We hypothesize that these recurrences were attributable to the antibiotics addressing the transient bacteremia that occurs in chronic group A streptococcal tonsillitis because antibiotics would kill any cells released (exported) from the biofilm and not allow those microbes to generate an immune response. The organisms still exist latently within both extra-and intracellular biofilms and thus they are protected from the effects of the antibiotics.
A word about the controls in our study: We believe psoriasis is a "double hit" phenomenon in which the We, among others, have previously described the presence ofbiofilms and their role in the pathogenesis of a variety of skin diseases, including atopic dermatitis, Lyme disease, and tinea versicolor,":" In these disease processes, the biofilms were extracellular rather than intracellular. More recently, we reported that intracellular biofilms were found in hippocampal specimens in patients with Alzheimer disease.IS
The distinction between extra-and intracellular biofilms is particularlyimportant because intracellular biofilms provide another levelofprotection against both the immune system and antibiotics, and thus they are increasingly difficult to eradicate." In the context of psoriasis, tonsillar intracellular biofilms may serve as a nidus ofinfection and can provide antigens that stimulate skin-homing T cells through molecular mimicry," This chronic state may help explain the relapsing and remitting nature of the psoriatic phenotype.
The current treatment paradigm for psoriasis is based on using topical and systemic agents to modify the immune pathways that contribute to keratinocyte proliferation and the development of psoriatic lesions. Despite the availabilityof multiple treatment modalities, including newer systemic immunomodulatory agents, patients often require life-long treatment and are subject to a host of side effects. Given our findings, it may be that immunomodulatorytherapies work too far downstream and do not directly address the causative entity.
Additional weight should likely be given to tonsillectomy in psoriasis because it has the capability of being curative with a single procedure. Also, studies investi-
